Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma

NCT02099396 is registered in ClinicalTrials.gov with China Association of Osteosarcoma Chemotherapy as lead sponsor.

NCT NCT02099396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02099396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma
Lead sponsor
China Association of Osteosarcoma Chemotherapy
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2014
Completion date
Not reported
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma